Stent Thrombosis-Risk Assessment and Prevention

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F10%3A00002616" target="_blank" >RIV/00216208:11120/10:00002616 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Stent Thrombosis-Risk Assessment and Prevention

Popis výsledku v původním jazyce

The development and use of stents has made percutaneous coronary intervention an effective (less restenosis), safe (treatment of emergency vessel closure during balloon angioplasty), and applicable (stents were developed for lesions of tortuous anatomy and complex situations) revascularization method. These features have firmly established stenting as first-line therapy in coronary revascularization. This life-saving device carries, however, the risk of a life-threatening complication-stent thrombosis.The article summarizes the facts about the incidence, histopathology, and risk factors of bare-metal as well as drug-eluting stent thrombosis. Future directions in reducing the incidence of stent thrombosis are also outlined.

Název v anglickém jazyce

Stent Thrombosis-Risk Assessment and Prevention

Popis výsledku anglicky

The development and use of stents has made percutaneous coronary intervention an effective (less restenosis), safe (treatment of emergency vessel closure during balloon angioplasty), and applicable (stents were developed for lesions of tortuous anatomy and complex situations) revascularization method. These features have firmly established stenting as first-line therapy in coronary revascularization. This life-saving device carries, however, the risk of a life-threatening complication-stent thrombosis.The article summarizes the facts about the incidence, histopathology, and risk factors of bare-metal as well as drug-eluting stent thrombosis. Future directions in reducing the incidence of stent thrombosis are also outlined.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

Z - Vyzkumny zamer (s odkazem do CEZ)

Rok uplatnění

2010

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cardiovascular Therapeutics

ISSN

1755-5914

e-ISSN

—

Svazek periodika

28

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

9

Strana od-do

—

Kód UT WoS článku

000281644000004

EID výsledku v databázi Scopus

—